Guangdong Tai'an Tang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- Type of securities to be delisted: Renminbi ordinary shares, stock abbreviation: *ST Tai'an, stock code: 002433.
- The Company's stock will resume trading on June 14, 2024, and enter the delisting transition period, which lasts for fifteen trading days, with the expected last trading date being July 4, 2024.
- During the delisting transition period, the stock will trade on the risk warning board. On the first trading day of the transition period, there will be no price fluctuation limits; thereafter, the daily price fluctuation limit will be 10%.
- Investors, securities companies, and other market participants are advised to settle stock pledge repurchase, agreed repurchase, margin financing, transfer, and Shenzhen Stock Connect transactions before the stock is delisted.
- For judicial freeze transactions that will expire between the delisting and the completion of the initial registration in the delisting sector, it is recommended that the competent authorities handle the renewal procedures in advance through the original enforcement channels before the stock is delisted.
On June 5, 2024, Guangdong Tai'an Tang Pharmaceutical Co., Ltd. received the decision from the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") regarding the termination of the Company's stock listing (Shenzhen Stock Exchange [2024] No. 435). The SZSE has decided to terminate the listing of the Company's stock.
I. Type of securities to be delisted, stock abbreviation, stock code
- Type of securities: Renminbi ordinary shares
- Stock abbreviation: *ST Tai'an
- Stock code: 002433